News

Show
news from

Freeline Reports New Data from Fabry Disease Program, Pipeline and Company Updates, Including Appointment of Pamela Foulds, MD as Chief Medical Officer, and Third Quarter 2021 Financial Results

Gyroscope Therapeutics Announces Sanofi Investment of up to $60 Million

Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Freeline Therapeutics to Present FLT180a Data at the 2021 ASH Annual Meeting

SwanBio Therapeutics Announces New Preclinical Data Demonstrating Proof of Principle for SBT101 Gene therapy as a Potential Treatment of Adrenomyeloneuropathy

Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher Disease

Load more

Search